retatrutide phase 2 trial results weight loss for loss: Study shows 30% body weight 💉 A triple-action once-weekly injection

Unknown Drug Interactions : BPC-157's activity on nitric oxide pathways and growth hormone receptors raises unresolved concerns about interactions with medications (NSAIDs, anticoagulants, and hormonal therapies)

Cagrilintide is a next-generation investigational peptide that functions as a long-acting amylin receptor agonist

A recent study found that patients with type 2 diabetes taking a GLP-1 receptor agonist (such as Mounjaro) may be at an increased risk for developing the debilitating condition

Promotes Healthy Aging Support Helps maintain cellular vitality and supports overall wellness

Semaglutide (Ozempic/Wegovy) FDA-Approved Indications Semaglutide comes in three FDA-approved forms: Ozempic (an injection for managing type 2 diabetes and reducing cardiovascular risks), Wegovy (an injection or tablet for chronic weight management and cardiovascular risk reduction), and Rybelsus (an oral tablet for type 2 diabetes)